Mindful Compassion Care Program for Nurses During COVID-19

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a mindfulness and compassion-focused program aimed at reducing psychological distress among nurses who have been working on the frontlines during the COVID-19 pandemic. It involves a parallel-group randomized controlled design with 72 participants, divided into intervention and control groups. The primary outcome will be measured using the Emotional Exhaustion subscale of the Maslach Burnout Inventory, while secondary outcomes will include measures of cynicism, professional efficacy, anxiety, and depression. The study aims to assess the feasibility and acceptability of this intervention in a high-stress healthcare environment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

To be included in the study, a participants will have to be:

* a nurse employed at AOUI for the past two years;
* working within intensive care units, infectious disease unit, pulmonary medicine and internal medicine units that have been converted to COVID-19 sub-intensive units;
* scoring above the cut-off score for the Emotional Exhaustion sub-scale (EX) of the MBI-GS (equal to or greater than 2.20) in accordance with Italian norms

Exclusion Criteria:

Respondents will be excluded if they:

* have participated in mindfulness-based interventions in the previous 6 months;
* show a score \< 2.20 in the EX subscale of the MBI-GS;
* are receiving psychosocial or psychiatric treatment. Participants allocated to the WL will be requested not to participate in a mindfulness course offered elsewhere.

Where it's running

• Università di Verona
  Verona, Italia, Italy Recruiting

Study contacts

• Study coordinator: Antonio Lasalvia
• Email: antonio.lasalvia@univr.it
• Phone: +39 045 8283901

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults

  This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.

  Recruiting Phase 4 Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland · NCT07287137

• Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals

  A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.

  Recruiting at 20 sites Phase 4 Sanofi · Fair Oaks, California and 19 other locations · NCT07861542

• Using voice patterns to detect burnout in healthcare workers

  This study tests whether speech and voice signals can reveal burnout and stress in clinicians and whether a stress-management device changes those voice markers.

  Recruiting Phase 4 Minneapolis Heart Institute Foundation · Minneapolis, Minnesota · NCT07780812

• Secutrelvir for nonhospitalized COVID-19 in teens and adults

  This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.

  Recruiting Phase 3 Shionogi Inc. · Multiple Locations · NCT07746544

• Mindfulness-Based Relapse Prevention for Peer Workers

  We’re testing whether Mindfulness-Based Relapse Prevention can help substance-use peer workers cut down on use and burnout compared with usual referrals to a 12-step program.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07741825

• Floatation-REST for frontline workers with post-traumatic stress symptoms

  This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.

  Recruiting Early Phase 1 Laureate Institute for Brain Research, Inc. · Tulsa, Oklahoma · NCT07710417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.